TARO
Taro Pharmaceutical Industries Ltd.
TARO
TARO
Delisted
TARO was delisted on the 21st of June, 2024.
71 hedge funds and large institutions have $150M invested in Taro Pharmaceutical Industries Ltd. in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $197M → $150M (-$46.4M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $7K
Holders
71
Holding in Top 10
2
Calls
–
Puts
$7K
Top Buyers
1 | +$1.6M | |
2 | +$1.33M | |
3 | +$1.04M | |
4 |
Millennium Management
New York
|
+$859K |
5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$759K |
Top Sellers
1 | -$9.87M | |
2 | -$8.03M | |
3 | -$2.37M | |
4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$760K |
5 |
Northern Trust
Chicago,
Illinois
|
-$347K |